TherapeuticsMD, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold TXMD, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
12
Funds holding
$660537
Total value held
Buying
6 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | $285569 | 129217 | — | Held |
| 2 | Blackrock, Inc. | $254470 | 115145 | — | Held |
| 3 | State Street Corp | $66521 | 30100 | — | Held |
| 4 | Northern Trust Corp | $41009 | 18556 | +2463 | +15.30% |
| 5 | Ubs Group Ag | $10299 | 4660 | +4660 | NEW BUY |
| 6 | Royal Bank Of Canada | $1000 | 833 | +643 | +338.42% |
| 7 | Jpmorgan Chase & Co | $657 | 293 | — | Held |
| 8 | Us Bancorp \De\ | $544 | 246 | — | Held |
| 9 | Wells Fargo & Company/Mn | $254 | 115 | — | Held |
| 10 | Citigroup Inc | $141 | 64 | +63 | +6300.00% |
| 11 | Barclays Plc | $49 | 22 | +22 | NEW BUY |
| 12 | Amalgamated Financial Corp. | $24 | 63477 | +63477 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.